Astragalus Candolleanus

Astragalus candolleanus  Royle.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Fabaceae; Papilionaceae.
Habitat The western Himalayas.
Ayurvedic Rudanti, Rudravanti.
Action Depurative, bechic, blood purifier (used in skin diseases). Root powder and decoction also used as an adjunct in tuberculosis.
Dosage Fruit—3–5 g powder. (CCRAS.)
Taxonomic Cohort Genus Astragalus (5 documented species); Family Fabaceae (25 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Astragalus candolleanus (taxonomically cited with authority Royle.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Fabaceae; Papilionaceae (primary family classification: Fabaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The western Himalayas.

Across classical and vernacular Indian systems of medicine, Astragalus candolleanus is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Rudanti, Rudravanti. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Astragalus candolleanus are: Depurative, bechic, blood purifier (used in skin diseases). Root powder and decoction also used as an adjunct in tuberculosis. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

The therapeutic activity of Astragalus candolleanus is grounded in its documented pharmacological actions (Depurative, bechic, blood purifier (used in skin diseases). Root powder and decoction also used as an adjunct in tuberculosis) and the characteristic secondary metabolite profile of the family Fabaceae.

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Astragalus comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Astragalus gummifer (Action: Demulcent, emollient (used for irritation of the internal mucosa, colitis, dry…); Astragalus hamosus (Action: Nervine tonic (used in nervous and catarrhal affections), antirheumatic…); Astragalus sarcocola (Action: Gum—antirheumatic, aperient, anthelmintic, emollient); Astragalus strobiliferus (Action: Gum—an Indian substitute for tragacanth (A. gummifer gum)). Comparing Astragalus candolleanus alongside its congeners in genus Astragalus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Fabaceae encompasses 25 documented medicinal species (1.38% of the 1,814-species flora). Other representative medicinal members of Fabaceae include: Astragalus gummifer (Tragacanth Gum), Astragalus hamosus (Tonkin bean), Astragalus sarcocola (Rudanti), Astragalus strobiliferus (Indian Gum tragacanth), Cyamopsis tetragonoloba (Kshudra Shimbi). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 25 medicinal species of family Fabaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Astragalus candolleanus are prescribed as follows: Fruit—3–5 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Astragalus candolleanus integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top